Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ): Rationale and Study Design of the Largest Global Prospective Cohort Study of Clinical High Risk for Psychosis. - Wannan CMJ; Nelson B; Addington J; Allott K; Anticevic A; Arango C; Baker JT; Bearden CE; Billah T; Bouix S; Broome MR; Buccilli K; et al. (Schizophrenia bulletin, 2024)